Cargando…

Radial artery as a second conduit gains momentum: The RAPCO trial

In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Simry, Walid, Afifi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272406/
https://www.ncbi.nlm.nih.gov/pubmed/34285901
http://dx.doi.org/10.21542/gcsp.2021.10
_version_ 1783721211463729152
author Simry, Walid
Afifi, Ahmed
author_facet Simry, Walid
Afifi, Ahmed
author_sort Simry, Walid
collection PubMed
description In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complete the surgical revascularization. For that purpose, SV remains the most commonly used conduit despite current evidence in favor of arterial grafts. To determine which conduit is best for grafting the second most important coronary artery, Buxton and colleagues have recently published the long term results of their “Radial Artery Patency and Clinical Outcomes (RAPCO)” trial.
format Online
Article
Text
id pubmed-8272406
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Magdi Yacoub Heart Foundation
record_format MEDLINE/PubMed
spelling pubmed-82724062021-07-19 Radial artery as a second conduit gains momentum: The RAPCO trial Simry, Walid Afifi, Ahmed Glob Cardiol Sci Pract Lessons from the Trials In coronary artery bypass grafting (CABG), the use of an internal mammary artery (IMA) to graft the left anterior descending coronary artery (LAD) improves survival and reduces the need for repeat revascularization. The other IMA, radial artery (RA), and saphenous vein (SV) have contested to complete the surgical revascularization. For that purpose, SV remains the most commonly used conduit despite current evidence in favor of arterial grafts. To determine which conduit is best for grafting the second most important coronary artery, Buxton and colleagues have recently published the long term results of their “Radial Artery Patency and Clinical Outcomes (RAPCO)” trial. Magdi Yacoub Heart Foundation 2021-06-30 /pmc/articles/PMC8272406/ /pubmed/34285901 http://dx.doi.org/10.21542/gcsp.2021.10 Text en Copyright ©2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
Simry, Walid
Afifi, Ahmed
Radial artery as a second conduit gains momentum: The RAPCO trial
title Radial artery as a second conduit gains momentum: The RAPCO trial
title_full Radial artery as a second conduit gains momentum: The RAPCO trial
title_fullStr Radial artery as a second conduit gains momentum: The RAPCO trial
title_full_unstemmed Radial artery as a second conduit gains momentum: The RAPCO trial
title_short Radial artery as a second conduit gains momentum: The RAPCO trial
title_sort radial artery as a second conduit gains momentum: the rapco trial
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272406/
https://www.ncbi.nlm.nih.gov/pubmed/34285901
http://dx.doi.org/10.21542/gcsp.2021.10
work_keys_str_mv AT simrywalid radialarteryasasecondconduitgainsmomentumtherapcotrial
AT afifiahmed radialarteryasasecondconduitgainsmomentumtherapcotrial